Lazard Asset Management’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $894K | Buy |
146,477
+136,022
| +1,301% | +$830K | ﹤0.01% | 1334 |
|
2025
Q1 | $79K | Buy |
10,455
+4,050
| +63% | +$30.6K | ﹤0.01% | 1877 |
|
2024
Q4 | $61K | Sell |
6,405
-27,390
| -81% | -$261K | ﹤0.01% | 1932 |
|
2024
Q3 | $199K | Buy |
33,795
+23,759
| +237% | +$140K | ﹤0.01% | 1612 |
|
2024
Q2 | $68K | Sell |
10,036
-36,711
| -79% | -$249K | ﹤0.01% | 1867 |
|
2024
Q1 | $359K | Sell |
46,747
-628
| -1% | -$4.82K | ﹤0.01% | 1132 |
|
2023
Q4 | $414K | Buy |
47,375
+15,998
| +51% | +$140K | ﹤0.01% | 1163 |
|
2023
Q3 | $228K | Buy |
31,377
+2,767
| +10% | +$20.1K | ﹤0.01% | 1347 |
|
2023
Q2 | $188K | Buy |
28,610
+2,349
| +9% | +$15.4K | ﹤0.01% | 1364 |
|
2023
Q1 | $89K | Buy |
26,261
+5,966
| +29% | +$20.2K | ﹤0.01% | 1574 |
|
2022
Q4 | $56K | Buy |
+20,295
| New | +$56K | ﹤0.01% | 1751 |
|
2022
Q1 | – | Sell |
-280
| Closed | -$1K | – | 2458 |
|
2021
Q4 | $1K | Buy |
+280
| New | +$1K | ﹤0.01% | 2254 |
|
2018
Q2 | – | Sell |
-37,803
| Closed | -$263K | – | 1095 |
|
2018
Q1 | $263K | Buy |
+37,803
| New | +$263K | ﹤0.01% | 815 |
|